[Letter: Prevention of hemophilia complications].
D000917:Antibody Formation; D001782:Blood Donors; D005169:Factor VIII / Q000009:adverse effects* / Q000627:therapeutic use; D006467:Hemophilia A / Q000517:prevention & control*; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D008134:Long-Term Care
D005169:Factor VIII
Hämophilie-Komplikationsprophylaxe.